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1980s, WHO has advocated for a focus on prevention, especially where the burden of prevalence is highest, specifically in women
from low- and middle-income countries (LMIC). The aim of the two studies presented here is to demonstrate a process to enhance
implementation efforts in fertility awareness programmes that could assist in preventing some forms of infertility, and increase
understanding of factors that could result in fertility problems. The fertility status awareness tool (FertiSTAT) for the Middle East was
adapted to provide an illustrative example of requirements for region- or country-specific adaptation. The mixed methods approach
used included a survey of international medical experts concerning the comprehensiveness of risks included in the original FertiSTAT
(Study I), and stakeholder meetings to assess the feasibility and acceptability of using an adapted FertiSTAT in the Middle East
(Study II). The results indicate that the content of the original FertiSTAT was acceptable but not comprehensive in its coverage
of potential risk factors; for example, it did not include genital tuberculosis, human immunodeficiency virus, consanguineous
relationships and female genital mutilation/cutting. Furthermore, stakeholder meetings revealed that implementation in the Middle
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Prevention focus
The World Health Organization (WHO) and World Bank
have identified secondary infertility as a global public health
issue (WHO/World Bank, 2011). WHO has advocated for
a focus on the prevention of secondary infertility, especially
in low- and middle-income countries (LMIC) where preva-
lence is highest (Mascarenhas et al., 2012; Van der Poel
and World Health Organization, 2012). The prevention of
fertility problems and promotion of ‘fertility care’ (Zegers-
Hochschild et al., 2017) is addressed in some higher income
countries and settings (National Women's Health Policy,
Australia; Macaluso et al., 2010), but is under-researched
and underserved in LMIC and lower-resource settings.
The gap in fertility care should be addressed to ensure
that policy meets reproductive needs across the lifespan,
and to promote equity of access through knowledge about
these issues in LMIC (Van der Poel and World Health
Organization, 2012). Improvements in fertility care could
also have broader health impacts through improvements in
prepregnancy health. Addressing an unmet need for family
planning and infertility services through the provision
of universal access to sexual and reproductive health care
are national targets within the sustainable development
goals (United Nations General Assembly, 2015), supported
through the WHO global reproductive health strategy (WHO,
Reproductive Health and Research, 2004). WHO considers
its intervention targets in reproductive health, including
fertility care, as being ‘of equal weight’ to strengthen the
attainment of sexual health as a whole (WHO, 2017). One
important aspect of fertility care is improving awareness
of the prevention of infertility by highlighting factors that
can have a negative impact on fertility or cause fertility
problems.Fertility awareness tools
‘Fertility awareness’ has been proposed to include knowl-
edge of reproduction, fecundity, fecundability, related risk
factors and reproductive options (Zegers-Hochschild et al.,
2017). Educational and information tools aimed at increasing
public and self-awareness about reproductive health and
fertility care have been developed recently in high-income
countries. These tools use diverse methods to increase
awareness including: (i) websites dedicated to fertility that
tailor the information which visitors receive according to the
risks they present on the site (e.g. ‘yourfertility’ website;
Hammarberg et al., 2013); (ii) public health initiatives that
use self-assessment tools as a hook to attract people to sites
that provide relevant fertility education (e.g. ‘test your
fertility’; De Cock, 2011); and, more recently (iii) fertility
assessment clinics where people can have their fertility
evaluated through history-taking and biomedical tests
(Hvidman et al., 2015; Petersen et al., 2015). This article
reports two studies describing the process used to examine
whether FertiSTAT, a fertility awareness tool developed in
the UK, could be acceptable for dissemination and imple-
mentation within other sociocultural contexts.FertiSTAT
FertiSTAT was developed as a self-administered tool for
women to increase personal awareness of risk factors that
negatively impact ability to achieve a pregnancy [available
in printed and online versions; see Bunting and Boivin,
2010 and online supplementary material]. The tool uses
22 lifestyle and reproductive questions (i.e. risk indicators)
to generate a risk profile and, based on this, personalized
fertility guidance and suggested actions (e.g. to change
behaviour, monitor symptoms until ready to attempt preg-
nancy, or seek medical advice now), weighted for impor-
tance via a colour-code system. The tool is appropriate
whether women are trying to become pregnant or are using
contraception. FertiSTAT was designed to assist women
make informed decisions about risks (e.g. lifestyle) and to
know when to seek timely medical advice if desired. The
risk indicators were identified from empirical research as
showing a reliable association with infertility, which has
been medically defined as the inability to become pregnant
after 12 months of unprotected intercourse or due to other
medical or functional diagnoses of a reproductive disorder
(Zegers-Hochschild et al., 2009, 2017). The FertiSTAT risk
indicators are global and are assumed to operate similarly on
fertility wherever people reside (e.g. similar effects of
smoking on fertility across countries). Using a multifactorial
weighted model, FertiSTAT was shown to discriminate to a
high degree (i.e. 85.8%) between fertile women and those
who had been medically diagnosed and confirmed infertile
(Bunting and Boivin, 2010). FertiSTAT can assist in public
health campaigns about fertility problems, and has been used
in Belgium (e.g. ‘test your fertility’; De Cock, 2011) and
international media (Portugal, Japan, UK), but has not been
evaluated or used in the Middle East to date.
FertiSTAT was selected over other available public aware-
ness options based on its strengths, namely more compre-
hensive risk coverage, use of critical thresholds for each risk
(e.g. number of cigarettes smoked, kilograms overweight),
weighting of risks (e.g. absence of periods versus irregular
periods), consideration of additive relationships between risks
(age, years infertile), validation through case–controlled
research studies (as described) and low cost (Bunting and
Boivin, 2010). FertiSTAT is inexpensive because it comprises
one sheet of paper and does not require maintenance
compared with other options (e.g. apps and websites). This
advantage is critical for successful dissemination in many
countries and settings, especially LMIC. Despite all of the
advantages listed, it was not known whether FertiSTAT would
be appropriate for wider global use.Geographic variation in risk
It is known that the global distribution of disease and the
corresponding patterns of health risks vary according to
geography (WHO, 2009). Variations in risks for fertility
problems and infertility have been explored in narrative
reviews (Bosdou et al., 2016; Ericksen and Brunette, 1996;
Leke et al., 1993; Sharma et al., 2009). These reviews
suggest that variations in the prevalence of cultural practices
(e.g. consanguineous marriages, female genital mutilation/
cutting), communicable disease [e.g. human immunodeficiency
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(e.g. dilatation and curettage) that could impact fertility do
exist, and should be reflected in educational efforts to
improve fertility awareness. A first step in adapting fertility
awareness tools such as FertiSTAT would be to determine
whether the risks included in the tool are comprehensive, and
are able to cover exposure to risks according to geographical
setting, other disease burdens or exposures, and sociocultural
factors.
Feasibility and cultural appropriateness
The usefulness of evidence-based educational tools is
improved if tools are culturally appropriate (Healey et al.,
2017). The effectiveness of addressing risk factors through
tailored educational health messages has been demon-
strated (Noar, 2006), including in reproductive health
(Baird, 2009). Adapting evidence-based tools and interven-
tions developed in one country for another raises several
issues about feasibility (Bowen et al., 2009) and cultural
appropriateness (Kreuter et al., 2003) that could be
addressed through stakeholder meetings. Feasibility data
help determine whether further evaluation of a health
intervention (e.g. service, product) is warranted. Feasibility
can cover diverse components: first, acceptability to
providers and users (e.g. suitability, attractiveness); second,
demand (e.g. individual or organizational intention to
use); third, practicality (e.g. resources needed); and fourth,
dissemination and implementation issues (e.g. constraints)
(Bowen et al., 2009). Consultation with stakeholder groups
and users prior to adaptation is useful to elicit relevant,
culturally appropriate information (Kreuter et al., 2003).
Stakeholders can help adapt tools to the surface charac-
teristics of a target group (e.g. appearance and language)
or to deeper sociocultural characteristics (e.g. values,
beliefs) that might affect their implementation and effec-
tiveness (Resnicow et al., 1999). The exchange between
attendees in a stakeholder meeting could allow more diverse
opinions to emerge than with individual surveys. A systematic
review of studies comparing health and mental health
services with and without culturally adapted interventions
showed better outcomes among the latter for a range of
services (e.g. improved uptake of HIV tests, decreases in
alcohol-induced problem behaviour; Healey et al., 2017).
These findings support an examination of the feasibility
and sociocultural appropriateness of using awareness tools
such as FertiSTAT outside of the setting of their initial
development.
Aim
The aim of this work was to determine the perceived
comprehensiveness, feasibility of use and acceptability of
FertiSTAT among multiple stakeholders (providers and users)
in settings outside of the development context (UK). A mixed
method process of adaption was undertaken. In Study I,
the aim was to ascertain the comprehensiveness of the
risk factors included in the original FertiSTAT. A survey of
doctors practising in diverse LMIC worldwide was used to
identify additional risk factors for inclusion when adapting
FertiSTAT for wider use. In Study II, stakeholder meetingswere used to collect qualitative data about the feasibility
and acceptability of using an adapted FertiSTAT that included
the additional risk factors identified in Study I in the Middle
Eastern region.Study I. Survey of medical experts to assess
the comprehensiveness of the FertiSTAT risk
factors and to identify potentially relevant
additional risk factors
Materials and methods
Participants and recruitment
A list of experts active in education and training in LMIC
(n = 106) was generated with input from a former Director
of Medical Education and the International Federation for
Fertility Societies, and by searching contact information
for fertility clinic websites in Africa and the Middle East
(n = 44). These medical experts were invited to participate
in the survey. Eligibility criteria included being a medical
doctor, and actively assessing and treating individuals with
potential fertility problems. Participants were not provided any
financial incentive for involvement. The School of Psychology
(Cardiff University) Ethics Committee provided review and
approval for the project.
Materials
Study questions were embedded in an online survey
generated with Qualtrics (Qualtrics, Provo, UT, USA). All
survey questions were indicated optional. The questionnaire
was developed specifically for the study and comprised
three sections. First, the 22 lifestyle and reproductive
risk factors in the original FertiSTAT were presented for
information to make respondents aware of the risks already
included. Second, a ‘structured list’ of additional risks not
included in the original FertiSTAT was presented, which
included medical conditions associated with fertility prob-
lems and additional risk factors identified from narrative
literature reviews of risk factors in diverse regions that
include LMIC and other lower-resource settings. For each
item on the ‘structured list’, participants were asked to
indicate whether the item should be considered for
inclusion as a risk factor for female infertility in an adapted
FertiSTAT (yes/no). An open text box provided space to
provide reason(s) or justification(s) for inclusion of the
particular risk factor. The third and final section was a
second open text box that asked participants to specify any
other risk factor that they felt was relevant to their country of
practice (hereafter ‘participant-generated list’). Again, par-
ticipants were asked to indicate a reason(s) or justification(s)
for inclusion of their proposed risk factor in an adapted
FertiSTAT tool.
Background sociodemographic and medical practice ques-
tions were asked (e.g. country of practice, type of specializa-
tion, number of years practising, healthcare sector). Country of
practice was classified into income countries (low, lower-
middle and upper-middle income) according to the Develop-
ment Assistance Committee (DAC) list of overseas development
aid (ODA) recipients (Organisation for Economic Co-operation
and Development, 2017).
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Participants were invited to the study via e-mail and
instructed to click on a hyperlink that led them to information
about the study, the consent form and the survey. At the end
of the survey was a ‘submit’ button that participants clicked
to submit their data.
Data analysis
Reasons given for inclusion of new risks were grouped
according to type (medical, reproductive or lifestyle). When
participants gave multiple reasons, descriptive statistics were
used to report frequency data.
Results
In total, 41 of 150 (27.3%) medical experts participated in
the survey. The majority of participants were from Africa
and the Middle East (63.4%, n = 26), and most participants
(75.6%, n = 31) were from low, lower-middle and upper-
middle income countries of ODA recipients. Of these,
51.6% (n = 16) practised in least-developed or low-income
countries (Sudan, n = 6; Uganda, Nepal, Kenya, Nigeria,
n = 2 each; Egypt, Paraguay, n = 1 each) and 48.4% (n = 15)
practised in ODA upper-middle-income countries (South
Africa, n = 10; Libya, Tunisia, Turkey, Uruguay, Panama,
n = 1 each). Remaining participants (22% of all participants)
practised in higher income countries not on the DAC list
(Russia, Spain, n = 2 each; Belgium, UK, USA, Kazakhstan,
Taiwan, n = 1 each). Of the 33 participants who responded
to the training question, almost all (32/33) had specialist
training in addition to training in obstetrics and gynae-
cology (e.g. reproductive medicine or reproductive endo-
crinology and infertility). On average, years of medical
practice was 28.7 [standard deviation (SD) 9.4] and years
of fertility practice was 19.3 (SD 10.75). Of the 34
participants who answered the question concerning their
setting, 50% (n = 17) were in the private sector alone, five
were in the public sector alone, nine were in both sectors,
and three were in other settings (e.g. academic institutions).
The average number of fertility patients (or couples) with
fertility problems managed per week was 31.58 (SD 18.4,
median = 30).
Table 1 shows the percentage agreement that risk factors
and medical conditions on the ‘structured list’ should be
included in an adapted FertiSTAT. The percentage agree-
ment varied, with medical and reproductive conditions
(e.g. cancer, HIV) generating higher endorsement for risks
than ‘practices’ (e.g. consanguinity). Specifically, 75.9–97.0%
of the total sample endorsed additional risk factors arising
from infection or communicable diseases (e.g. HIV, genital
tuberculosis or postpartum infection), 50.0–86.5% endorsed
non-communicable diseases (e.g. diabetes, lupus), and
37.5–54.2% endorsed cultural practices (e.g. female genital
mutilation/cutting). Overall, 25 participants suggested other
risk factors relevant to their country of practice. Factors
included: medical (e.g. medications, thyroid disease), repro-
ductive (e.g. adhesions/fibroids), or lifestyle and environment
(e.g. vitamin D deficiency, occupation/exposure). Lifestyle
and environment were suggested less commonly.
Table 1 also includes frequency of justifications reported
for inclusion of the risk factors. Few participants provided aspecific reason, but this depended on the type of risk. For
example, more people endorsing a reproductive condition
provided a justification than those endorsing a practice. A
reason was reported for approximately half of the participant-
generated risk factors, mainly for proposed lifestyle risks.
Study II. Assessing the feasibility and acceptability
of implementing an adapted FertiSTAT in the
Middle East among multiple stakeholders
Methods
Participants and recruitment
Two meetings were held in the Middle East. The first
was held in Egypt in November 2016 at the 2016 annual
conference of the Middle East Fertility Society (MEFS). The
mission of MEFS is to improve fertility care for couples in the
Arab world and Middle East through the transfer of medical
knowledge and the promotion of scientific research. The
MEFS Administration identified 30 medical experts practising
in the Middle East and planning to attend the MEFS
conference, and sent them an e-mail inviting them to
participate in the study. Of the 30 invited, 28 (93.3%) agreed
to participate and 21 were able to attend the stakeholder
meeting (4 November 2016) facilitated by RRB and SvdP.
Seven experts were unable to attend group meetings due to
scheduling conflicts, and participated in individual inter-
views with the facilitators at a later time on the same day
as the group session. The second stakeholdermeeting was held
in Sudan in December 2016 under the guidance and leadership
of the National Reproductive Health Programme (NRHP) of the
Sudanese Federal Ministry of Health. NRHP sent invitations
to policy makers, representatives from womens' and youth
groups, and local experts in individual and group qualitative
researchmethodologies in Sudan. Of the 15 individuals invited,
11 were able to attend the meeting facilitated by RRB and JB.
The invitations for all meetings included an agenda which
stated that the comprehensiveness of an adapted FertiSTAT
and the feasibility and acceptability of its use in the Middle
East would be discussed. No incentives were offered to
attendees, but lunch was provided at both meetings.
Materials and procedure
The FertiSTAT discussed during stakeholder meetings
(adapted FertiSTAT) comprised the original 22 risk factors
plus an additional five factors endorsed as relevant to LMIC
from Study I. Of the 36 risk factors investigated in the survey
(15 structured list, 21 patient-generated), five warranted
further consideration for inclusion in FertiSTAT due to
consensus among survey participants and consistency with
extant empirical literature on their importance, exclusion
from the originalFertiSTAT, and evidence garnered from
ongoing systematic reviews and meta-analysis showing
association with fertility (ongoing research). These were:
consanguinity, female genital mutilation/cutting, HIV, gen-
ital tuberculosis and bacterial vaginosis, and water-pipe
smoking as an additional method of using tobacco. A section
on non-communicable diseases (e.g. diabetes) was also
included. Prior to the meetings, collaborators (EFS, former
Director of MEFS) advised the meeting facilitators that the
use of a self-administered tool in the Middle East might
Table 1 Percentage of respondents to the item who endorsed risk factors in structured list (1a), participant-generated risk factors
(1b) and main reasons provided for risk factor inclusion in FertiSTAT.
Risk factors Endorsed
n/N (%)
Principal reasons given to justify endorsement
(n/N of responses)
1a. Structured list Unsure
n/N (%)
Specific reason
(n/N, %)
No reason given
n/N (%)
Practices FGM/C 13/24 (54.2) 2/13 (15.4) Reduces ovarian reserve (1/13, 7.7) 10/13 (76.9)
Consanguinity 13/26 (50.0) 1/13 (7.7) Recurrent miscarriage (2/13, 15.4) 10/13 (76.9)
Water-pipe smoking 9/24 (37.5) 3/9 (33.3) Reduces ovarian reserve (1/9, 11.1) 5/9 (55.6)
Reproductive
factors
Bacterial vaginosis 12/27 (44.4) 0/12 (0) Recurrent miscarriage (1/12, 8.3);
tubal damage (1/12, 8.3)
10/12 (83.3)
HIV 22/29 (75.9) 4/22 (18.2) Reduces ovarian reserve (3/22, 13.6);
endometrial damage (6/22, 27.3)
9/22 (40.9)
GTB 32/33 (97.0) 2/32 (6.3) Reduces ovarian reserve (1/32, 3.1);
Asherman syndrome (adhesions)
(5/32, 15.6); tubal damage (7/32, 21.9);
endometrial damage (3/32, 9.4)
14/32 (43.8)
Postabortion
infection
34/36 (94.4) 2/34 (5.9) Asherman syndrome (adhesions) (7/34, 20.6);
tubal damage (10/34, 29.4);
endometrial damage (2/34, 5.9)
13/34 (38.2)
Postpartum
infection
28/30 (93.3) 2/28 (7.1) Asherman syndrome (adhesions) (7/28, 25);
tubal damage (7/28, 25);
endometrial damage (2/28, 7.1)
10/28 (35.7)
Repeated D&C 26/30 (86.7) 1/26 (3.8) Asherman syndrome (adhesions) (9/26, 34.6);
cervical damage (1/26, 3.8)
15/26 (57.7)
Cervical
electrocautery
14/25 (56.0) 0/14 (0) Endometrial damage (1/14, 7.1);
cervical damage (2/14, 14.3)
11/14 (78.6)
Medical
conditions a
Diabetes 26/35 (74.3)
Kidney disease 22/32 (68.8)
SLE (lupus) 25/34 (73.5)
Sickle cell anaemia 16/32 (50.0)
Cancer 32/37 (86.5)
1b. Participant-
generated list
Unsure
n/N (%)
Specific reason
(n/N, %)
No reason given
n/N (%)
Medical Medications (pharmaceutical,
psychotropic or traditional)
3/25 (12.0) 0/3 (0) Toxins (3/3, 100) 0/3 (0)
Male factor (e.g. cancer treatment) 6/25 (24.0) 0/6 (0) Reduced male fertility
(6/6, 100)
0/6 (0)
Thyroid disease/treatment 7/25 (28.0) 0/7 (0) (0/7, 0) 7/7 (100)
Anaemia 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Autoimmune diseases 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Cushing syndrome 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Chronic liver disease 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Inflammatory bowel disease 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Reproductive Adhesions/fibroids 2/25 (8.0) 0/2 (0) Tubal damage (2/2, 100) 0/2 (0)
Vaginitis 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Dyspareunia 1/25 (4.0) 0/1 (0) Reduced coitus (1/1, 100) 0/1(0)
Pelvic tuberculosis 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Pregnancy-related infection 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Hyperprolactinaemia 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100)
Lifestyle Low vitamin D 1/25 (4.0) 0/1 (0) Poor oocyte quality
(1/1, 100)
0/1 (0)
Occupation/exposure 3/25 (12.0) 0/3 (0) Male factor (3/3, 100) 0/3 (0)
IUD 2/25 (4.0) 0/2 (0) Risk of PID (1/2, 50) 1/2 (50)
Extreme exercise 1/25 (4.0) 0/1 (0) Reduction in pulatile GnRH
release (1/1, 100)
0/1 (0)
Undernutrition/anorexia 1/25 (4.0) 0/1 (0) (0/1, 0) 0/1 (0)
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1b. Participant-
generated list
Unsure
n/N (%)
Specific reason
(n/N, %)
No reason given
n/N (%)
Vaginal lubricants 1/25 (4.0) 0/1 (0) May be spermicidal (1/1, 100) 0/1 (0)
Anal sex 1/25 (4.0) 0/1 (0) Increases risk of prostatitis
(1/1, 100)
0/1 (0)
n, number responding ‘yes’ to inclusion in adapted FertiSTAT; N, total number responding to question (yes or no); NR, not reported; unsure,
participant indicated not knowing how risk factor affects fertility; FGM/C, female genital mutilation/cutting; GTB, genital tuberculosis; D&C,
dilatation and curettage for any reason; SLE, systemic lupus erythematosus; IUD, intrauterine device; PID, pelvic inflammatory disease;
GnRH, gonadotrophin-releasing hormone.
Sample size varies by question.
a Participants were not asked to provide reasons for these medical conditions.
Lifestyle
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typical clients and patients. Therefore, the authors developed
two versions of the adapted FertiSTAT for discussion with
stakeholders: a flipchart version appropriate for community
health workers (trained individuals from the community who
are not necessarily medically trained) to use with clients;
and a checklist version appropriate for healthcare providers
(physicians and nurses) to use with their patients. The
flipchart is one of the methods used by WHO and other non-
government organizations (NGOs), such as the Population
Council,at the level of primary care in regions of lower
literacy when communicating reproductive health issues
(e.g. contraception) (WHO, 2005). The flipchart version was
two-sided with one page facing the client and the other facing
the provider. The page facing the client depicts information
using pictures and simple graphics; the other page faces the
service provider and displays corresponding key questions,
detailed information and discussion points for the provider
to educate the client on the FertiSTAT item. The checklist
version showed, on a single page, the list of FertiSTAT risk
indicators that providers could check off as affecting the
consulting patient. Checklists are used increasingly to effi-
ciently condense a large quantity of information, describe
essential evidence-based criteria, and enhance the objectivity
and reproducibility of communications between practitioners
and patients, including settings where there is low literacy
(Hales et al., 2008). As noted, the adapted versions (flipchart,
checklist) included 28 items: the 22 original FertiSTAT risk
indicators, five additional risk factors identified in Study I, and
an item including all themedical conditions. It should be noted
that two of the 22 items concerned risk factors for men
(mumps during puberty, undescended testicle).
At both meetings, participants were given a presentation
regarding the development and use of the original FertiSTAT.
The adapted version (flipchart, checklist) was then pre-
sented and discussed in relation to comprehensiveness of risk
indicators, applicability, feasibility and cultural/regional
acceptability. Discussion included specifics of implementa-
tion, such as target audience, setting and practicality of use
(e.g. format). Due to the sensitivity of the topics, recording
devices were not utilized; however, detailed notes (including
direct quotes) were taken by SvdP and RRB for the first set
of meetings, and by a Sudanese research assistant for the
meeting in the Sudan.
Data analysis
RRB and SvdP conducted thematic analysis (Braun and
Clarke, 2006) and derived codes from all meeting notes(inductive coding) about perceived feasibility and acceptabil-
ity of the adapted FertiSTAT. Codes with the same meaning
(e.g. ‘population of interest’ and ‘target population’) were
combined. Coders discussed and reached agreement on
whether each code communicated a unique meaning or fit
with other existing codes. Each coder organized codes into
main themes, and these were discussed between coders to
ensure the cohesiveness of each theme and consistency with
the overall meanings in the dataset. Subthemes within the
main themes were also identified to facilitate understanding
and presentation of the results. Participant quotes were
used to illustrate meanings. The use of parentheses within
quotations in the results section below indicates text added
for clarity, while omitted text is represented using ‘(…)’.
All illustrative quotations are from medical experts, unless
profession is specified. The meeting in which the quote
originated has been indicated using M1 (Meeting 1) and M2
(Meeting 2).
Results
The attendees of the first meeting at the MEFS conference
were 28 medical experts practising in 10 countries in the
Middle East. All were ODA recipients except Saudi Arabia.
Countries were low or lower-middle income (Sudan, Egypt,
Syria) or upper-middle income (Algeria, Iraq, Jordan, Lebanon,
Libya, Turkey). The attendees of the second meeting were 11
stakeholders from Sudan, comprising representatives from: the
Ministry of Health (NRHP), medical societies (Sudanese Society
of OBGYN and Sudanese Reproductive Health and Embryology
Society), reproductive health expert from the United Nations
Population Fund (UNFPA), national NGOs [e.g. Regional
Institute of Gender, Diversity, Peace and Rights, Sudan
(RIGDPR), HIV Unit of JASMAR Human Security Organization),
a previous patient, epidemiologists, medical doctors from
local universities (University of Khartoum, Ahfad University,
National Ribat University), and medical experts practising in
the public and private sectors. As shown in Table 2, thematic
analysis resulted in five main themes, described below.
Need for fertility awareness in the Middle East
Fertility awareness was considered to be necessary and
timely: “there is a niche for such tools especially because
our societies are geared towards childbearing” (M1) due to
perceived lack of “information about risk factors”, “miscon-
ception about what is a risk” (M1) and lack of knowledge
about when to seek medical advice causing people to seek
Table 2 Themes emerging from thematic analysis of data gathered at both meetings (see text for elaboration on themes).
Theme Summary of theme
Need for fertility awareness in the Middle East Fertility awareness was endorsed based on societal emphasis on childbearing and
perceived widespread misconceptions about fertility and lack of fertility knowledge
Content acceptability and suggested tool
changes
The content of the adapted FertiSTAT that was acceptable
The wording of certain items found to be unacceptable or only acceptable if
modified to be better understood and more culturally sensitive
Target audience for adapted FertiSTAT Suggestions for the appropriate age and marital status of the target audience on
which to use the adapted FertiSTAT included: couples preparing for marriage,
newlyweds and young unmarried individuals (men and women)
Suggestions about subgroups (e.g. refugees) as separate target audiences were made
Setting for implementation Regional level settings: disagreement about the possibility of a regional tool
Country/community level settings: urban and rural settings may have different needs
Possible settings for dissemination and implementation include: schools, primary
healthcare facilities, infertility clinics (tertiary level), community and media
Need for further research (setting specific)
and a working group
Next steps require setting up a working group to finalize the content of the
material and oversee necessary regional research
Areas for future research: assess implementation in proposed settings and target
populations; identify which format would be suitable for which setting; field testing
the wording used to appropriately communicate complex, sensitive or stigmatizing
topics to determine acceptability and alternatives; evaluate research to ensure
highest possible quality of research (empirically sound); ethical problems
(e.g. screening) will lead to huge demand and services need to be available
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on these topics would help “reduce the burden” (M1)
on healthcare systems and individuals, and potentially
reduce the prevalence of known preventable causes
of infertility “if they know when to get help” (M1).
Participants also spoke more generally about the topic.
The social stigma of infertility was highlighted for men: “(…)
they (men) deny having the problem because it is shameful,
makes him less of a man” (M2); “male infertility is a stigma”
(patient, M2). Another issue supporting increasing fertility
awareness was misunderstanding of information that
people obtained from the internet: “the main problem is
the internet, where individuals look up on say PCOS
(polycystic ovary syndrome) and immediately find infertility
as the end” (M2).
Content acceptability and specific tool changes
There was consensus that, “with some adjustment to
the language” (M1), an adapted FertiSTAT could potentially
be culturally acceptable and used in the Middle East. The
absence of PCOS from the adapted FertiSTAT was noted
because it was common in the practice of some doctors: “(…)
30% of my patients have PCOS” (M2).
However, there was conflicting opinion about wording.
Some suggested that certain risk factors should be removed,
altered or only communicated to specific audiences due to
their sensitive nature:
“Sex with multiple partners is unacceptable in a community of
husbands and wives (…) the word ‘partner’ particularly should
not be used” (M2).
“Items regarding things like multiple partners need to be
delivered in a sensitive manner (…) use ‘extramarital affairs’ or
‘previous relationships’ (…) but you have to ask” (M2).However, others felt that the adapted FertiSTAT tool
could be used as designed in their country or clinic setting.
The terminology was “comprehensible” with some modifi-
cation of “medical terminology like endometriosis and PID
(pelvic inflammatory disease) (that) should be replaced
with more understandable terminology, which would require
deliberation at length and with several experts” (M1). Some
also felt that wording/phrasing might need to be “country
specific (…) or specific to particular community settings
(within countries)” (M1).
A reproductive health expert from a Sudanese NGO
(RIGDPR, M2) mentioned the importance of the provider in
asking about risk factors: “you have to be careful when asking
these women (…) your body language, choice of words” (M2).Target audience
Diverse target audiences were suggested for the adapted
FertiSTAT tool. A reproductive health expert from a
Sudanese NGO (RIGDPR, M2) suggested that the materials
should “target couples who are about to get married” (M2),
and a representative from UNFPA in Sudan noted that
“school children (and) university students are the main
targets” (M2). Recommendations appeared to depend on
views of current social norms: “You can't talk about these
things (sex) with people who are not married yet (M1);
“Times are changing (…) in some places” (M1). However, in
both meetings, integration into existing programmes for
young people was recommended. For example, premarital
counselling which is “mandatory about certain medical
disorders such as HIV and hepatitis B and C to receive a
marriage certificate in Egypt” (M2), and “free youth work-
shops held by the Ministry of Youth, targeting couples who are
about to get married and educating them about things like
family planning, HIV testing” (RIGDPR, NGO, M2).
17An evaluation of comprehensiveness, feasibility and acceptability of a fertility awareness educational toolOther specific targets were “unique subcultures within
each country that may have different needs and level of
understanding (…) (or) acceptability” (M1). One example
was the refugee population “who despite their circum-
stances are very keen on having children and the need for
fertility awareness is acute” (M1). Broader dissemination
was also suggested: “these tools should be tested at
community level targeting the general population” (M1).
Setting for implementation
The fourth main theme concerned the macro/micro level
setting for implementation of fertility awareness tools.
There were suggestions that there should be “a Middle East
version” (M1) that was tailored to the needs of that specific
region. However, others disagreed: there “cannot be a
regional tool” and we “cannot (even) have a country tool”
and “a regional tool may not be possible but a national
tool would be beneficial” (M1). This view was based on the
diversity of people within the region or a country, and the
exposure to different risks; for example, female genital
mutilation/cutting is highly prevalent in Sudan and Egypt,
but is almost non-existent in Lebanon and Oman. Further,
different settings could have different needs; for example,
there may be a “need to develop a rural and an urban version
(format) for each country” (M1). A reproductive health
expert from a Sudanese NGO (RIGDPR) made a similar
suggestion, emphasizing the difference in literacy levels
across the country (M2).
At the country/community level, several suggestions for
use and dissemination were made, including schools,
primary healthcare facilities, infertility clinics (tertiary
level), media and community (as described above). There
was agreement that the primary healthcare level setting
would help reach the widest audience. Several medical
experts (M1 and M2) expressed an opinion that the school
setting (regardless of age of pupils) would not be appropri-
ate due to the sensitive issues raised (e.g. sexual activity
and illegal drug use), but not all agreed. Some felt that
adolescents were already exposed to these issues (M1 and
M2). Others, including an epidemiologist (M2) and represen-
tatives from Sudanese NGOs (M2), expressed the view that
“integrating the material in the curriculum of schools and
universities would be best” (M2). This was further reinforced
by ongoing activities; for example,in Sudan, the “Ministry of
Health and Ministry of Education with the support of UNICEF
are in the process of rolling out (in schools) an adolescent
health module on fertility, targeting ages 10–19 years”
(NRHP representative, M2). It was stated that “interventions
have to start early (…) first place should be at the school,
train the teachers, give the information to the educators”
(M2). There was consensus that further research was
necessary to ascertain acceptability and utility in schools,
and if and how to target different adolescent and young
adult age groups (M1 and M2).
In addition, a checklist was suggested for use by nurses or
the patients themselves in fertility clinics (tertiary care)
prior to the consultation with the fertility specialist (M1
and M2). Although the fertility clinic may seem late for
prevention, often couples who attend these clinics are not
infertile and do not require fertility interventions, but do
require reproductive health education including fertility
awareness knowledge. Participants expressed the view that“all my clients are infertile and this (adapted FertiSTAT)
would be useless (at this stage)” (M1), while others reinforced
the well-known statistic that “we get many (patients) who
are NOT infertile, but they think they are, so it (adapted
FertiSTAT) would be very helpful” (M1) in making patients
aware of risks identifying those who might require medical
attention.
The use of media such as television, radio, internet and
social media (e.g. Facebook, WhatsApp) was discussed as
potential viable dissemination platforms in both meetings.
In Sudan, the material could be disseminated in group
format rather than one-on-one: “village meetings, commu-
nity gatherings, rather than individual(ly)” or via print media
“in clinics, outpatient departments, magazines” (M2). A
representative from a local university (M2) suggested using
the flipchart version and taking advantage of existing health
promotion programmes like the “rural extension program
at Ahfad University” to improve fertility awareness. Every
year, Ahfad University sends students to rural villages to
deliver health education messages; fertility could be one of
these topics. Midwives and healthcare visitors were also
suggested as potential local healthcare providers who could
be trained to disseminate this information, as they are the
“main care providers in rural areas where 80% of deliveries
are at home” (M2). Finally, the demographic characteristics
of participants (e.g. education, socio-economic status)
were perceived to possibly necessitate the use of “different
tools/formats for different settings” (M1). For example,
the provider flipchart would be useful for settings where
individuals have lower education levels, the checklist would
be helpful within a fertility care clinic or health centre, and
a self-administered questionnaire would be suitable only for
settings where potential users are “well educated” (M1).
Need for further research (setting specific) and a working
group
More research was thought to be necessary for adapting
the original FertiSTAT prior to implementation within the
Middle East. The MEFS experts thought that the creation of
a working group that could “finalize the content of the
material” (M1) and oversee necessary regional research
was the logical next step for implementation. In addition,
research was needed for wording of guidance to ensure the
appropriate assignment of blue, yellow, orange or red flags
for new risk factors (M1 and M2). Prospective testing in
multifactorial models would be required to detect how these
additional risk indicators would alter prediction values
compared with the original FertiSTAT prediction capacity
(Bunting and Boivin, 2010). These research gaps were
perceived to be essential to ensure appropriate guidance or
referral (i.e. audience, format, wording) and to maintain the
integrity of FertiSTAT as a validated tool. It was noted that
the “integration of fertility awareness tools and research
regarding testing different formats” would require the
involvement of “professional societies” and “public health
experts who would be more able to advise on where within
existing healthcare services the tools can be integrated and
what level of content (difficulty)” (M1). There was concern
over research quality, and one participant stated that
“the research (would) need to be well-coordinated and
implemented (…) one bad application or extreme negative
outcome could potentially destroy the whole project (and
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empirically sound, requiring “systematic reviews and proof of
principle for themodel for adaptation” (M1) including research
design for pilot testing of tools and adaptation process. Finally,
there was concern about ethics; an epidemiologist stated
“this project can be very complex, the aim of the educational
program is prevention through screening programs; however,
when that (the screening) starts (and may identify risks to
or fertility problems), there will be a huge demand (for access
to fertility care) that may cause an ethical problem, you have
to provide services or a referral pathway to cope with the
demand generated by the screening” (M2).
General discussion
Principal findings
The main finding of the studies was that using fertility
awareness tools in contexts outside their development
requires adaptation of risk factors, language of communica-
tion and methods of dissemination.
Comprehensiveness of risk factors
An important issue for awareness tools is that the risks they
include should be comprehensive and relevant to the region,
country or community settings within which the tool will be
used. The survey revealed that medical experts primarily
from Africa and the Middle East (63%) considered the original
FertiSTAT to lack some risks relevant in their country of
practice. These perceptions were in line with published
accounts of importance of investigating region-specific risk
factors in the Middle East (Bosdou et al., 2016; Serour, 2002)
and other regions (Leke et al., 1993) for prevention and
treatment of infertility. The omission of relevant risk factors
in the present adaptation begs the question of whether it
would ever be possible to achieve a fertility awareness tool
that has a complete list of risk factors that could be used
in different regions of the world. Consensus on key risk
factors for other health awareness tools has been achieved
(e.g. prepregnancy health; Frayne et al., 2016). We believe
that consensus could be achieved for the field of fertility
awareness, and would evolve gradually as the evidence
on risk factors is systematically reviewed and evaluated.
This consensus could also preclude the need for generating
multiple versions of FertiSTAT to fit within countries
and within settings. The process of adaptation used in the
present studies (survey and stakeholder meetings) could
facilitate accessing the relevant information for consensus.
There was variation in the level of endorsement for
risks. Variation could reflect the reality that less endorsed
risks associated with cultural practices (e.g. female genital
mutilation/cutting, water-pipe smoking) were actually less
risky for fertility than the communicable (e.g. HIV, genital
tuberculosis) or non-communicable (e.g. diabetes, lupus)
risks that are more highly endorsed. Alternatively, it could
be that evidence about less endorsed risks such as cultural
practices and their impact on fertility is not robust, not
yet adequately assessed or not yet communicated to or
accepted by medical experts. Future research needs to
update knowledge about poorly known or understood risks,and communicate that in training. The reasons/justifications
provided for the ‘reproductive’ risk factors were in line with
those provided in existing literature on causal mechanisms
that would underpin training, showing its importance in what
doctors know. Training should be updated about other risks
as evidence of their level of influence (whether significant
or not) is accumulated. However, it should be noted that it
was not possible to fully evaluate understanding of mecha-
nisms of action or other factors that could explain variation
in endorsement because the majority of participants did
not provide a reason/justification for endorsing a risk. As
FertiSTAT has been empirically validated, any newly en-
dorsed and proposed risk factor needs to be subjected to
systematic review and meta-analysis (when feasible) before
inclusion in an adapted FertiSTAT is empirically warranted.
Some assumptions made in developing the original
FertiSTAT were questioned in the present studies. In the
original FertiSTAT, medical conditions (e.g. diabetes) were
excluded on the grounds that the general practitioner
or disease specialist would have informed affected patients
about potential risks to their fertility, making the need
to raise awareness of such risks unnecessary in a fertility
awareness tool (Bunting and Boivin, 2010). However, the
results of Study I suggest that this assumption may not apply
widely. Not all participating medical experts knew the
fertility effects of the medical conditions examined; for
example, 14% did not agree that cancer could be a risk for
reduced fertility. This finding is consistent with an interna-
tional systematic review that postdates the original FertiSTAT,
showing that approximately one-third of cancer survivors
surveyed did not recall being told about the effects of cancer
or its treatment on their fertility or reproductive potential
(Tschudin et al., 2010). Of course, it could be that doctors
and oncologists know about risks but do not provide infor-
mation due to low accessibility of treatment or options to
resolve infertility. This possibility also needs to be consid-
ered. However, providing evidence-based education and
information that enables patients to make informed choices,
even when these are few, is consistent with ethical medical
practice. In turn, evidence gathered from patients who
benefit from this knowledge will help to impact national
policies that ensure greater access to health prevention and
care, which are critical components for all health problems.
Together these findings suggest that assumptions underlying
inclusion or exclusion of risk factors in fertility awareness
tools should be examined, especially when introducing a
tool in a new country within settings where there is limited
access to universal health care, or where there is inade-
quate adherence to, or lack of, best practice guidelines in
reproductive care or other health areas impacting fertility.Feasibility and acceptability
The concept of using a tool to increase fertility awareness
was accepted and perceived to be feasible. However, some
challenges exist. The use of a self-administered version of
FertiSTAT was not considered to be appropriate for the typical
client or user in the Middle East, and provider-administered
flipcharts or checklists were preferred due to lower education
and literacy. Content and wording were challenged, and
perceived to require being made appropriate for the country
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“appropriate” is in reference to social conventions about
permissibility of discussing taboo topics with different
members of a community, reinforcing social norms as powerful
drivers of medical healthcare-seeking, especially in LMIC
(Finlayson and Downe, 2013; Thaddeus and Maine, 1994). It
should be noted that hesitation about taboo topics could
also be due to the significant penalties or shame of engaging
in illegal activities in Muslim countries (e.g. alcohol use;
Islam and alcohol, 2012). Together, violation of social or legal
norms could be very problematic for individuals and also
for medical doctors who learn about them. These issues
identified for the Middle East could also be relevant for
other countries wanting to adapt FertiSTAT or other fertility
awareness tools.
Some of the stakeholders questioned the value of fertility
awareness in the absence of, or very limited potential of,
affordable services to improve fertility “to cope with the
demand generated by the screening”. FertiSTAT was
developed to increase informed decision-making about risk
factors and assist in timely medical help-seeking when signs
of disease were present (Bunting and Boivin, 2010). The
signs, symptoms and preventable causes of fertility prob-
lems are not widely known in many countries, especially
in LMIC (Bunting et al., 2013). Knowledge is valuable in
itself for people to understand the factors that affect
their health. Indeed, education is one of the components
of health interventions most consistently associated with
better health (including reproductive health; Baird et al.,
2009). Without disease awareness, prevention is difficult
to achieve; for example, people cannot reduce exposure to
risk factors (e.g. lifestyle, environmental), make informed
decisions about cultural practices affecting fertility (e.g.
consanguinity, female genital mutilation/cutting), or seek
timely (often inexpensive) care to reduce the effects in the
early stages of progressive disorders (e.g. endometriosis), or
for symptoms of fertility-related disorders that are ignored
or normalized at primary care (e.g. heavy bleeding, pelvic
pain). Thus, people could benefit even if (more costly)
treatments were not affordable to them. Nevertheless, it
is true that many countries now have fertility clinics (see
worldwide list; Dyer et al.; 2016), but not all care available
is affordable. Ongoing initiatives to develop and implement
methods that can lower the cost of interventions will help
reduce costs. Furthermore, WHO recognizes the importance
of fertility care in reproductive health programmes (WHO,
2017), and has initiated a number of activities to address
fertility care within healthcare systems and services (van der
Poel, 2016). In time, this recognition should help improve
accessibility of treatment.Limitations
There were limitations that should be acknowledged. The
low survey response rate and the invitation to selected
highly experienced medical experts working within the
private sector could introduce bias. The risk profile and
overall health of patients seen by such doctors could differ
from those of general practitioners or gynaecologists
working in public clinics. However, given that fertility care
health services are mainly based within the private sector inLMIC surveyed to date (IFFS Surveillance, 2016; Sullivan
et al., 2013), survey responses do reflect those patients
most likely to be treated. More research is needed on the
risk profile of untreated (and publicly treated) groups. There
was greater representation in the survey from regions that
have more fertility clinics (e.g. South Africa). More clinics
could reflect better access to care and greater willingness
to address this stigmatized topic, potentially biasing results
towards a more favourable view of fertility awareness
initiatives. Respondents did not answer all questions on the
survey, and the cause of non-response for specific items is
not known. Non-response could be due to lack of knowledge or
unwillingness to identify specific causes for reduced fertility,
especially if these might attribute blame to a specific gender
for a couple's problem. Despite these limitations, the survey
and stakeholder meetings did comprise a diverse group of
participants from countries that differed sufficiently from the
UK (i.e. in cultural majority, geography, healthcare system) to
inform the examination of whether the original FertiSTAT
could be considered for wider use. The conclusion is that it is
not, but it could be adapted to achieve that goal.
Future research
As noted, research is required to review and synthesize the
data available on the risk factors that were not included in
the original FertiSTAT and to develop appropriate guidance.
Future research should aim to develop a fertility awareness
tool for men, as the issue of male fertility was raised in
both stakeholder meetings. The original FertiSTAT was
developed and validated in women. It includes only two
reliable predictors of reduced male fertility (i.e. mumps
during puberty, undescended testicle). Since FertiSTAT was
published, more rigorous studies of risks and fertilization in
men have been performed (e.g. male obesity; Campbell
et al., 2015) and it may be possible to generate a valid male
FertiSTAT. Testing feasibility and acceptability would also
be necessary because perceptions of male fertility and men's
quality of life differ across countries (Sexty et al., 2016),
including in the Middle East (Inhorn, 2012). After such steps
have been taken, the process of globalizing FertiSTAT
and similar tools requires more implementation research
to validate their predictive value across countries, and to
demonstrate their value in such settings.
Conclusion
The processes used in the present studies concur with cross-
cultural adaptation guidelines that recommend consulta-
tions with health experts from the target population before
implementation (Beaton et al., 2000; Guillemin et al.,
1993). Globalizing health awareness should aim to ensure
recognition of diversity in the opinions of experts and
advisors, with the aim of accommodating the needs of the
end-user. The principal lesson learnt through these studies
was that fertility awareness tools such as FertiSTAT cannot
be superimposed on target populations that might differ from
the populations where such tools were originally developed.
Although risk factors could have a common underlying
mechanism globally, it would be a mistake to assume that
this universality necessarily implies similarity in the fertility
20 RR Bayoumi et al.risk factor profile to which people are individually exposed
globally, or the method by which awareness of risk could be
enhanced. FertiSTAT would benefit from inclusion of addi-
tional risk indicators in line with its introduction in new
countries. This paper has presented a process of adaptation
that could be used as other countries and regions become
interested in FertiSTAT and other fertility awareness tools.
It is critical to address these risk factors in order to sustain
healthy fertile lives.
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